Microfluidic Droplet Screening for Synthetic Microbial Communities

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for predicting microbial community interactions and environmental dependencies are limited by combinatorial complexity, making it difficult to rationally engineer beneficial consortia in a scalable and cost-efficient manner.

Innovation Solution

A microfluidic screening platform that enables parallel screening of microbial communities encapsulated in droplets, allowing for the construction and testing of synthetic communities at a scale of ~100,000 to ~108 communities per day, with optical screening and droplet merging to identify microbial and chemical compound interactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If empirical screening of microbial communities is performed to identify beneficial consortia, then accurate assessment of microbial interactions can be achieved, but the combinatorial complexity makes the process logistically complex and time-consuming

Engineering Contradiction:
Improveassessment accuracyVSAvoidscreening throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The system segments the microbial community assessment into discrete droplet units, each containing specific microbial combinations. By partitioning the complex combinatorial space into manageable droplet segments that can be independently generated and screened, the system achieves high-throughput parallel assessment without sacrificing combinatorial coverage

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from traditional single-well or plate-based screening to a droplet-based parallel system, effectively adding a dimension of parallelism. Multiple microbial combinations are assessed simultaneously in thousands of droplets, transforming a sequential process into a massively parallel operation that overcomes combinatorial complexity

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If comprehensive sampling of microbial community combinations is performed, then accurate identification of synergistic interactions is achieved, but the number of liquid handling processes increases significantly

Engineering Contradiction:
Improvecomprehensive sampling coverageVSAvoidliquid handling complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system employs self-organizing droplet generation and automatic microwell filling where droplets spontaneously distribute into microwells based on their physical properties. This self-service mechanism eliminates the need for complex programmed liquid handling to achieve comprehensive combinatorial sampling, as the system automatically generates and distributes all required microbial combinations

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention replaces complex mechanical liquid handling systems with a simplified droplet-based approach. Instead of using robotic pipettes and complex dispensing mechanisms to create microbial combinations, the system uses droplet generation and passive filling methods, substituting mechanical complexity with fluid-based self-organization

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates comprehensive assessment of microbial community combinations by maximizing tested combinations while minimizing liquid handling processes, enabling rapid identification of synergistic interactions.

Implementation Method 1

individual droplets in user-selected adjacent microwells are merged into a single merged assay, optionally by electrocoalescence, thermal coalescence or acoustic coalescence

Methodology Applied
Scientific EffectElectrocoalescence:

Implementation Method 2

individual droplets in user-selected adjacent microwells are merged into a single merged assay, optionally by electrocoalescence, thermal coalescence or acoustic coalescence

Methodology Applied
Scientific EffectThermal coalescence:

Implementation Method 3

individual droplets in user-selected adjacent micrawells are merged into a single merged assay, optionally by electrocoalescence, thermal coalescence or acoustic coalescence

Methodology Applied
Scientific EffectAcoustic coalescence:

Implementation Method 4

the optical screening includes measurement of luminescence and/or fluorescence

Methodology Applied
Scientific EffectLuminescence: Luminescence

Implementation Method 5

the optical screening includes measurement of luminescence and/or fluorescence, optionally where the fluorescence of one or more agents such as Alexa Fluor 488, Alexa Fluor 555, Alexa Fluor 594 and/or Alexa Fluor 647 is measured

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS12577526B2Massively parallel on-chip construction of synthetic microbial communities
Publication Date: 2026.03.17 THE BROAD INST INC
  • US12577526B2 patent drawing
  • US12577526B2 patent drawing
  • US12577526B2 patent drawing

AI summary

The present disclosure relates to compositions and methods for combinatorial assessment of nanoscale droplets, as specifically exemplified by massively parallel assessment of spatially-directed (while agnostic as to precise droplet content) combinations of droplets harboring distinct and independently identifiable microbial types and/or chemical compounds or mixtures. More particularly, the disclosure relates to a platform and methodologies for identifying advantageous (including synergistic, additive, etc.) microbial interactions and/or chemical compound or mixture interactions with microbes in a manner that allows for binary, trinary, etc. combinatorial assessments to be performed across a range of many discrete input types of microbes (e.g., 6-16 or more discrete input microbial types), to an extent capable of approaching comprehensive sampling and measurement of microbial community combinations from a selected panel of microbial inputs, optionally also in the presence of chemical compounds or mixtures (e.g., test compounds or mixtures for antimicrobial effect).